TransCode Therapeutics Says Peer-Reviewed Cancers Publication Shows TTX-MC138 Produced Significant Survival Benefit In Preclinical Mouse Model Of Breast Cancer Bone Metastasis

Benzinga Newsdesk www.benzinga.com Positive 94.6%

Neg 0% Neu 0% Pos 94.6%

Comments

No comments yet. Be the first!